Tuesday, July 28, 2015 12:38:17 PM
Dr. George Melnik
Senior Technical Advisor
Dr. Melnik , our Senior Technical Advisor, has been working very closely with Dr. Refai to advance the CSpace technology.
Dr. Melnik has had an extensive career in display technology research and development. He has been awarded 17 patents and authored numerous publications. For the last seven years Dr. Melnik has been a technology consultant specializing in display product development and also serving as an expert witness in patent law cases involving display technologies. Previously, Dr. Melnik worked with several startup companies on improving their display technologies and products. Prior to becoming a consultant, Dr. Melnik worked for 15 years at Philips where he drove the development of several novel technologies, including the liquid-crystal-on-silicon technology that was the basis for Philips’ groundbreaking rear projection HDTV. While at Philips, Dr. Melnik held positions in research, product development, and manufacturing. His last position held at Phillips was as the Director of Strategic Projects. Dr. Melnik was also instrumental in the early development of active matrix liquid crystal displays while at General Electric. Dr. Melnik received his Ph.D. in 1987 from the Liquid Crystal Institute of Kent State University. He is a senior member of the Society for Information Display and is presently the chairman of their mid-Atlantic chapter.
Recent CRTG News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:51:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 06:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:41:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:40:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:38:33 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2023 08:36:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 12:24:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM